SPE Capital has acquired a majority stake in Vital, Tunisia's leading nutritional supplements producer, marking their ninth investment and aiming to enhance growth and market presence.

Information on the Target

Founded in 2000, Vital is Tunisia's foremost manufacturer of dietary supplements and herbal medicines. With a robust portfolio featuring over 400 high-quality branded products, Vital produces around 8 million units annually, which are marketed both domestically and internationally. The company has established its leadership in the nutritional supplements sector, supported by consistent organic growth and ongoing product innovation. With a workforce of approximately 400 employees, including a substantial number of managerial staff, Vital has solidified its place as the industry's front-runner in Tunisia.

Industry Overview in Tunisia

The nutritional supplements industry in Tunisia has experienced significant growth over the past several years, driven by increasing health awareness among consumers and a rising demand for natural products. This trend is reflected in the expanding market for organic and herbal supplements, which has become a key segment of the broader healthcare and wellness sector. The government's commitment to enhancing healthcare services further supports industry expansion, with policies aimed at fostering innovation in health-related products.

Tunisia's regulatory environment has also evolved, creating opportunities for local and international companies to invest in the health sector. Underscored by an improving trade balance and growing foreign direct investment, the m

View Source

Similar Deals

Avenue Venture Opportunities Fund II, L.P. Spruce Biosciences, Inc.

2026

Growth Equity & Expansion Capital Bio Therapeutic Drugs United States of America
Primus Capital RxAnte

2026

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) United States of America
819 Capital Partners RiverD International

2026

Growth Equity & Expansion Capital Bio Diagnostics & Testing Netherlands
Futura SGR Carol

2026

Growth Equity & Expansion Capital Managed Healthcare (NEC) Italy
WindRose Health Investors, LLC Avalon Healthcare Solutions

2026

Growth Equity & Expansion Capital Medical & Diagnostic Laboratories United States of America
Verdane Clue

2026

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) Germany

SPE Capital

invested in

Vital

in 2023

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert